| Company Name: |
ChemOrigin Pharm |
| Tel: |
15026428026 19002516454 |
| Email: |
ChemOrigin@126.com |
N-[5-(1H-imidazol-2-yl)-2,4-dimethylphenyl]-4-[(pyridin-2-yl)methoxy]benzamide manufacturers
- AZD7254
-
- $1980.00
-
2026-05-11
- CAS:1126366-28-6
- Purity:
- Supply Ability: 10g
|
| | N-[5-(1H-imidazol-2-yl)-2,4-dimethylphenyl]-4-[(pyridin-2-yl)methoxy]benzamide Basic information |
| | N-[5-(1H-imidazol-2-yl)-2,4-dimethylphenyl]-4-[(pyridin-2-yl)methoxy]benzamide Chemical Properties |
| Boiling point | 577.5±50.0 °C(Predicted) | | density | 1.262±0.06 g/cm3(Predicted) | | pka | 13.33±0.31(Predicted) |
| | N-[5-(1H-imidazol-2-yl)-2,4-dimethylphenyl]-4-[(pyridin-2-yl)methoxy]benzamide Usage And Synthesis |
| Uses | AZD7254 is an orally active Smoothened (SMO) inhibitor with an EC50 of 1.0 nM against sonic Hh protein (shh)[1]. | | in vivo | AZD7254 (40 mg/kg; p.o.; twice daily for 10 days) exhibits 42% tumor growth inhibition in an HT29-MEF (murine embryonic fibroblast) co-implant xenograft model[1]. | | References | [1] Yang B, et al. Heteroarylamide smoothened inhibitors: Discovery of N-[2,4-dimethyl-5-(1-methylimidazol-4-yl)phenyl]-4-(2-pyridylmethoxy)benzamide (AZD8542) and N-[5-(1H-imidazol-2-yl)-2,4-dimethyl-phenyl]-4-(2- pyridylmethoxy)benzamide (AZD7254). Bioorg M DOI:10.1016/j.bmc.2019.115227 |
| | N-[5-(1H-imidazol-2-yl)-2,4-dimethylphenyl]-4-[(pyridin-2-yl)methoxy]benzamide Preparation Products And Raw materials |
|